Jefferies Starts Alto Neuroscience (ANRO) at Buy, 'Precision Psychiatry with 4 Big Readouts for $1B+ Indications'
Tweet Send to a Friend
(Updated - February 27, 2024 3:37 AM EST)
Jefferies analyst Andrew Tsai initiates coverage on Alto Neuroscience (NYSE: ANRO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Andrew Tsai initiates coverage on Alto Neuroscience (NYSE: ANRO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
